A pharmaceutical composition for the prevention and / or treatment of diabetes, its preparation method and uses.

An oral preparation was prepared using a traditional Chinese medicine combination of gypsum, salt-processed anemarrhena, wine-processed coptis, trichosanthes root, yam, licorice tablets, and dried ginger. This preparation solved the problems of side effects and drug resistance in the treatment of type 2 diabetes with Western medicine, achieved a significant hypoglycemic effect, and has good potential for clinical application.

CN123101641APending Publication Date: 2026-11-17TEACHING HOSPITAL OF CHENGDU UNIV OF T C M
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510621195.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-05-14
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing Western medicine treatments for type 2 diabetes have side effects and drug resistance issues, and cannot fundamentally cure diabetes. Traditional Chinese medicine has the advantages of multiple targets and multiple pathways in the treatment of diabetes, but there is a lack of effective drug combinations.

Method used

This product combines five traditional Chinese medicines: gypsum, salt-processed anemarrhena, wine-processed coptis, trichosanthes root, yam, licorice root slices, and dried ginger. It is prepared into an oral formulation through water extraction and the addition of dextrin to exert a synergistic hypoglycemic effect.

Benefits of technology

This drug composition significantly reduces fasting blood glucose levels, has promising clinical application prospects, and provides a safe and effective treatment option for diabetes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005402560430000052
    Figure BDA0005402560430000052
Patent Text Reader

Abstract

This invention provides a pharmaceutical composition for the prevention and / or treatment of diabetes, its preparation method, and its uses, belonging to the field of traditional Chinese medicine. The pharmaceutical composition of this invention is prepared from the following raw materials in the indicated weight ratios: 25-35 parts gypsum, 15-25 parts salt-processed anemarrhena asphodeloides, 12-18 parts wine-processed coptis chinensis, 8-12 parts trichosanthes kirilowii, 8-12 parts dioscorea opposita, 4-6 parts licorice root slices, and 4-6 parts dried ginger. The raw materials in this pharmaceutical composition complement each other, exerting a synergistic effect in lowering blood sugar. This pharmaceutical composition can be used to prepare drugs for the prevention and / or treatment of diabetes and has good clinical application prospects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of traditional Chinese medicine, specifically relating to a pharmaceutical composition for the prevention and / or treatment of diabetes, its preparation method, and its uses. Background Technology

[0002] Diabetes mellitus is a chronic metabolic disease characterized by hyperglycemia, mainly classified into type 1 diabetes, type 2 diabetes, and other special types. Type 2 diabetes (T2DM) is the most common type, accounting for over 90% of all diabetes cases. The pathogenesis of type 2 diabetes is complex, primarily related to insulin resistance and insulin secretion defects. In recent years, with changes in lifestyle and population aging, the incidence of type 2 diabetes has increased significantly globally, especially in developing countries. It is estimated that by 2035, the number of people with type 2 diabetes worldwide will reach 592 million. Currently, the treatment of type 2 diabetes mainly relies on Western medicines, such as metformin, sulfonylureas, and insulin. While these drugs can effectively control blood sugar levels, they also have some limitations. For example, metformin may cause gastrointestinal discomfort, and insulin treatment may cause hypoglycemia and weight gain. Furthermore, long-term use of Western medicines may lead to drug resistance and cannot fundamentally cure diabetes. Therefore, finding safer and more effective treatment options is an important direction of current research.

[0003] In Traditional Chinese Medicine (TCM) theory, diabetes is classified as "Xiao Ke Bing" (wasting and thirsting disease), with its main pathogenesis being Yin deficiency and dryness-heat. In recent years, the application of TCM in the treatment of diabetes has gradually gained attention. TCM has the characteristics of multi-target and multi-pathway action, which can regulate the patient's metabolic state holistically, improve insulin resistance, and protect pancreatic islet cells. Many TCM compound formulas have been proven to have certain efficacy in type 2 diabetes, such as Yuquan Wan and Jinqi Jiangtang Pian. Providing more drug combinations with excellent blood sugar-lowering effects is of great significance for diabetic patients, offering them more medication options. Summary of the Invention

[0004] The purpose of this invention is to provide a pharmaceutical composition for the prevention and / or treatment of diabetes, a method for its preparation, and its use.

[0005] This invention provides a pharmaceutical composition for the prevention and / or treatment of diabetes, which is prepared from active pharmaceutical ingredients in the following weight ratios:

[0006] 25-35 parts raw gypsum, 15-25 parts salt-processed anemarrhena asphodeloides, 12-18 parts wine-processed coptis chinensis, 8-12 parts trichosanthes kirilowii, 8-12 parts yam, 4-6 parts licorice root slices, and 4-6 parts dried ginger.

[0007] Furthermore, the aforementioned pharmaceutical composition is prepared from the following active pharmaceutical ingredients in the indicated weight ratios:

[0008] 30 parts raw gypsum, 20 parts salt-processed anemarrhena, 15 parts wine-processed coptis, 10 parts trichosanthes root, 10 parts yam, 5 parts licorice root slices, and 5 parts dried ginger.

[0009] Furthermore, the aforementioned pharmaceutical composition is a drug prepared by adding pharmaceutically acceptable excipients or auxiliary ingredients to the active ingredients of raw drug powder, water or organic solvent extract in various weight proportions.

[0010] Furthermore, the drug is an oral preparation.

[0011] Furthermore, the oral preparation is a decoction, tablet, powder, granule, oral liquid, or capsule.

[0012] The present invention also provides a method for preparing the aforementioned pharmaceutical composition, comprising the following steps:

[0013] (1) Take the raw materials in portions by weight;

[0014] (2) Grind into powder or extract with water or organic solvent;

[0015] (3) Add pharmaceutically acceptable excipients or auxiliary ingredients to obtain the final product.

[0016] Furthermore, in step (2), water is added for extraction;

[0017] And / or, in step (3), the excipient or auxiliary ingredient is dextrin.

[0018] Further, in step (2), the extraction method is to add 10 to 12 times the amount of water, soak for 0.5 to 1 hour, decoct 3 to 5 times, decoct for 1 to 3 hours each time, filter, and take the filtrate.

[0019] The present invention also provides the use of the aforementioned pharmaceutical composition in the preparation of a hypoglycemic medicament.

[0020] Furthermore, the drug is a drug for the prevention and / or treatment of diabetes.

[0021] According to the Chinese Pharmacopoeia 2020 Edition, Part I:

[0022] Raw gypsum: Gypsum is a sulfate mineral belonging to the gypsum group, mainly containing hydrated calcium sulfate (CaSO4·2H2O). After mining, impurities and silt are removed. The processing method for raw gypsum involves crushing the gypsum, removing impurities, and grinding it into coarse powder.

[0023] Salt-processed Anemarrhena: Anemarrhena is the dried rhizome of Anemarrhena asphodeloides Bge., a plant of the Liliaceae family. Anemarrhena slices are prepared by removing impurities, washing, moistening, cutting into thick slices, drying, and removing hairs. The processing method for salt-processed Anemarrhena is to take the slices and stir-fry them according to the salt-processing method (General Rule 0213) until dry.

[0024] Wine-processed Coptis: Coptis is the dried rhizome of *Coptis chinensis* Franch., *Coptis deltoidea* CYCheng et Hsiao, or *Coptis teeta Wall.*, all belonging to the Ranunculaceae family. The processing method for wine-processed Coptis is to take clean Coptis and stir-fry it until dry according to the wine-processing method (General Rule 0213). For every 100 kg of Coptis, use 12.5 kg of rice wine.

[0025] Trichosanthes root: Trichosanthes root is the dried root of Trichosanthes kirilowii Maxim. or Trichosanthes rosthornii Harms, both belonging to the Cucurbitaceae family. The preparation method for Trichosanthes root is to briefly soak it until thoroughly moistened, cut it into thick slices, and then dry it.

[0026] Yam: Yam is the dried rhizome of Dioscorea opposita Thunb., a plant in the Dioscoreaceae family. The processing method for yam involves removing impurities from hairy or smooth yams, separating them by size, soaking them until fully hydrated, cutting them into thick slices, and then drying them.

[0027] Licorice slices: Licorice is the dried root and rhizome of Glycyrrhiza uralensis Fisch., Glycyrrhiza inflata Bat., or Glycyrrhiza glabra L., all belonging to the Fabaceae family. The processing method for licorice slices involves removing impurities, washing, soaking thoroughly, cutting into thick slices, and drying.

[0028] Dried ginger: Dried ginger is the dried rhizome of Zingiber officinale Rosc., a plant in the ginger family. The processing method for dried ginger is to remove impurities, soak briefly, wash, moisten thoroughly, cut into thick slices or chunks, and then dry.

[0029] The pharmaceutical composition of the present invention is explained as follows:

[0030] In this formula, raw gypsum and Coptis chinensis (processed with wine) are the principal herbs. Raw gypsum is sweet and pungent, slightly cold in nature; its coldness overcomes fire, its pungentness dissipates heat, and its sweetness enters the spleen and stomach to clear internal heat in the Yangming channel. Coptis chinensis (processed with wine) is extremely bitter and cold, clearing heat and drying dampness; Liu Hejian praised it as a "holy medicine for treating diabetes." The two herbs, one clearing excess heat in the Yangming Qi level and the other clearing excess heat in the Yangming stomach and intestines, complement each other perfectly. Anemarrhena asphodeloides and Trichosanthes kirilowii are the assistant herbs. Anemarrhena asphodeloides is bitter, cold, and moist; its bitterness and coldness help clear heat and assist gypsum in clearing heat, while its moistness generates fluids and protects the Yin of the lungs, stomach, and kidneys. Trichosanthes kirilowii, according to the *Jinkui Yaolue*, treats "thirst that does not subside," and its sweetness, coldness, and smoothness also clear phlegm and "can wash away the grime and stagnant heat in the chest and diaphragm" (*Shanghan Zhengzhi Zhunsheng*). Dried ginger and Dioscorea opposita are the adjuvant herbs. Dried ginger warms the middle and prevents cold and cooling herbs from harming the spleen and stomach, thus acting as a counteracting agent. Dioscorea opposita replaces rice; its white color enters the lungs, its sweet taste enters the spleen, and its thick liquid benefits the kidneys. Licorice is used as the guiding herb, its sweet and mild nature harmonizes the middle and regulates the effects of other herbs. When these seven herbs are used together, they directly counteract the raging fire, cleanse the blood vessels of sugar toxicity, and replenish the yin of the spleen, stomach, and lungs to strengthen the body's vital energy and preserve body fluids.

[0031] Compared with the prior art, the beneficial effects of the present invention are as follows:

[0032] This invention provides a pharmaceutical composition in which the active pharmaceutical ingredients work synergistically to exert a synergistic hypoglycemic effect. This pharmaceutical composition can be used to prepare drugs for the prevention and / or treatment of diabetes, and has promising clinical application prospects.

[0033] Obviously, based on the above description of the present invention, and according to common technical knowledge and conventional methods in the field, various other modifications, substitutions or alterations can be made without departing from the basic technical concept of the present invention.

[0034] The following detailed embodiments further illustrate the above-described content of the present invention. However, this should not be construed as limiting the scope of the present invention to the following examples. All technologies implemented based on the above-described content of the present invention fall within the scope of the present invention. Detailed Implementation

[0035] The raw materials and equipment used in the specific embodiments of the present invention are all known products, obtained by purchasing commercially available products.

[0036] BS-460 Veterinary Biochemical Analyzer (Shenzhen Mindray Bio-Medical Electronics Co., Ltd.); S1010E Handheld Centrifuge (Schoolex, USA); TDZ4K Low-Speed ​​Benchtop Centrifuge (Changsha High-Tech Xiangyi Centrifuge Instrument Co., Ltd.); SpectraMAX Plus384 Microplate Reader (Meigu Molecular Instrument Co., Ltd.); HH-6 Constant Temperature Water Bath (Shanghai Lichen Bangxi Instrument Technology Co., Ltd.); PW-480 Automatic Plate Washer (Shenzhen Huisong Technology Development Co., Ltd.); SSY-II Pure Water System (Sichuan Shuisiyuan Environmental Technology Co., Ltd.).

[0037] Example 1: Preparation of the pharmaceutical composition of the present invention

[0038] Prescription: 30g gypsum, 20g salt-processed anemarrhena, 15g wine-processed coptis, 10g trichosanthes root, 10g yam, 5g licorice root slices, 5g dried ginger.

[0039] Preparation method: Weigh each herb according to weight, add 10 times the amount of water as prescribed, soak for 0.5 hours, decoct 3 times, 1 hour each time, filter, concentrate the filtrate to an appropriate amount, add dextrin, granulate, granulate, and package. One dose is packaged into 3 bags.

[0040] Example 2: Preparation of the pharmaceutical composition of the present invention

[0041] Prescription: 25g raw gypsum, 15g salt-processed anemarrhena asphodeloides, 12g wine-processed coptis chinensis, 8g trichosanthes kirilowii, 8g yam, 4g licorice root slices, 4g dried ginger.

[0042] Preparation method: Same as in Example 1.

[0043] Example 3: Preparation of the pharmaceutical composition of the present invention

[0044] Prescription: 35g gypsum, 25g salt-processed anemarrhena, 18g wine-processed coptis, 12g trichosanthes root, 12g yam, 6g licorice root slices, 6g dried ginger.

[0045] Preparation method: Same as in Example 1.

[0046] Comparative Example 1: Other drug combinations (Baihu Decoction)

[0047] Prescription: 43.85g gypsum, 29.23g salt-processed anemarrhena rhizome, 14.62g yam, 7.31g licorice root slices.

[0048] Preparation method: Same as in Example 1.

[0049] Comparative Example 2: Other drug combinations (Loulian Pills)

[0050] Prescription: 47.5g of Coptis chinensis (processed with wine), 31.67g of Trichosanthes kirilowii, and 15.83g of dried ginger.

[0051] Preparation method: Same as in Example 1.

[0052] The following specific experimental examples demonstrate the beneficial effects of the present invention.

[0053] Experimental Example 1: Hypoglycemic Effect of the Pharmaceutical Composition of the Present Invention

[0054] 1. Drugs and reagents

[0055] The hypoglycemic effect of the pharmaceutical compositions prepared in Example 1 and Comparative Examples 1 to 2 was studied. In addition, Metformin Hydrochloride Tablets [Merck KGaA, batch number Y09010] were used as a control. This test example also involves Streptozotocin [sigma, batch number WXBF2887V]; Mouse Insulin ELISA Kit (Shanghai Zhuocai Biotechnology Co., Ltd., batch number E20250221-36531).

[0056] 2. Laboratory Animals

[0057] Healthy SPF-grade KM mice, male, with a body weight of 35-45 g, were provided by Chengdu Dashuo Experimental Animal Co., Ltd., with the animal production certificate number: SCXK (Chuan) 2021-030. The animals were housed in the animal room of the Shi'erqiao Campus of Chengdu University of Traditional Chinese Medicine, which meets the requirements of the Ethics Committee of the Experimental Animal Center of Chengdu University of Traditional Chinese Medicine. The indoor temperature is controlled at (22±3)°C, and the humidity is (60±10)%. The high-fat and high-sugar diet (nutritional components: moisture 9.3%, protein 13.4%, fat 14.3%, total sugar 23.5%, crude fiber 2.7%, crude ash 4.4%, calcium 0.83%, total phosphorus 0.71%) and the normal diet are all provided by Chengdu Dashuo Technology Co., Ltd.

[0058] 3. Modeling and Administration

[0059] After 7 days of adaptive feeding, 7 mice were randomly selected as the blank control group, and the rest were switched to high-fat and high-sugar diet feeding. The model was established by combining high-fat and high-sugar diet with intraperitoneal injection of STZ 30 mg / kg. After modeling, the mice were continuously fed with high-fat and high-sugar diet. After 3 days, fasting blood glucose was measured under the condition of fasting with free access to water. Mice with fasting blood glucose ≥10 mmol / L were selected, and mice with the same or similar blood glucose values were divided into the model group, metformin group, Comparative Example 1 group, Comparative Example 2 group and Example 1 group according to the random number table method by number, with 7 mice in each group (SPSS 27.0 was used for statistical analysis of blood glucose values after grouping, and there was no statistically significant difference among groups). The metformin group was administered intragastrically with metformin solution at 0.26 g / kg, each traditional Chinese medicine group (Comparative Example 1 group, Comparative Example 2 group and Example 1 group) was administered intragastrically at a crude drug dosage of 19.95 g / kg, and the blank control group and the model group were administered intragastrically with an equal volume of 0.9% sodium chloride solution, once a day for 4 consecutive weeks.

[0060] 4. Sampling and Detection

[0061] After the last administration, the experimental mice were fasted with free access to water for 12 h, then anesthetized, and blood was collected through the abdominal aorta to detect the fasting blood glucose (FBG) value.

[0062] 5. Statistical Analysis

[0063] Statistical analysis was performed using SPSS 27.0 software; measurement data were expressed as mean ± standard deviation; one-way ANOVA was used for comparisons among multiple groups; and p < 0.05 was considered statistically significant.

[0064] 6. Conclusion

[0065] The comparison results of fasting blood glucose levels in each group are shown in Table 1. The fasting blood glucose (FBG) of the model group mice was significantly higher than that of the blank control group (P<0.05). Compared with the model group, the FBG of each intervention group (metformin group, comparative example 1 group, comparative example 2 group, and example 1 group) was significantly reduced (P<0.05). Among them, the hypoglycemic effect of comparative example 1 and comparative example 2 groups was not statistically significant compared with the metformin group (P>0.05). The fasting blood glucose of example 1 group decreased most significantly, and the difference was statistically significant compared with comparative example 1 group, comparative example 2 group, and metformin group (P<0.05), but not statistically significant compared with the blank group (P>0.05). This indicates that the active pharmaceutical ingredients in the drug composition of example 1 of the present invention complement each other and exert a synergistic hypoglycemic effect. It can be used to prepare drugs for the prevention or treatment of diabetes.

[0066] Table 1. Comparison of fasting blood glucose levels among groups

[0067]

[0068] Note: *P<0.05.

[0069] In summary, this invention provides a pharmaceutical composition in which the active pharmaceutical ingredients work synergistically to achieve a synergistic hypoglycemic effect. This pharmaceutical composition can be used to prepare drugs for the prevention and / or treatment of diabetes, and has promising clinical application prospects.

Claims

1. A pharmaceutical composition for the prevention and / or treatment of diabetes, characterized in that: It is prepared from the following raw materials in the indicated weight ratios: 25-35 parts raw gypsum, 15-25 parts salt-processed anemarrhena asphodeloides, 12-18 parts wine-processed coptis chinensis, 8-12 parts trichosanthes kirilowii, 8-12 parts yam, 4-6 parts licorice root slices, and 4-6 parts dried ginger.

2. The pharmaceutical composition according to claim 1, characterized in that: It is prepared from the following raw materials in the indicated weight ratios: 30 parts raw gypsum, 20 parts salt-processed anemarrhena, 15 parts wine-processed coptis, 10 parts trichosanthes root, 10 parts yam, 5 parts licorice root slices, and 5 parts dried ginger.

3. The pharmaceutical composition according to claim 1 or 2, characterized in that: It is a drug prepared by adding pharmaceutically acceptable excipients or auxiliary ingredients, with the active ingredients being the original powder of the raw drug in various weight proportions, water or organic solvent extracts.

4. The pharmaceutical composition according to claim 3, characterized in that: The drug is an oral preparation.

5. The pharmaceutical composition according to claim 4, characterized in that: The oral preparations include decoctions, tablets, powders, granules, oral liquids, and capsules.

6. A method for preparing the pharmaceutical composition according to any one of claims 1 to 5, characterized in that: It includes the following steps: (1) Take the raw materials in portions by weight; (2) Grind into powder or extract with water or organic solvent; (3) Add pharmaceutically acceptable excipients or auxiliary ingredients to obtain the final product.

7. The method according to claim 6, characterized in that: In step (2), water is added for extraction; And / or, in step (3), the excipient or auxiliary ingredient is dextrin.

8. The method according to claim 7, characterized in that: In step (2), the extraction method is to add 10 to 12 times the amount of water, soak for 0.5 to 1 hour, decoct 3 to 5 times, decoct for 1 to 3 hours each time, filter, and take the filtrate.

9. Use of the pharmaceutical composition according to any one of claims 1 to 5 in the preparation of a hypoglycemic medicament.

10. The use according to claim 9, characterized in that: The drug is a medication for the prevention and / or treatment of diabetes.